Holen Sie sich die Stockscreener-App
0.5159
3.23%
-0.0172
Handel nachbörslich:
.52
0.0041
+0.79%
Finanzdaten der Alx Oncology Holdings Inc-Aktie (ALXO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
21.37%
37.76
|
48.02 | 53.27 | 36.78 | 32.20 |
| Interest Income/Expense |
2.89%
0.427
|
0.415 | 0.391 | 0.372 | 0.387 |
| Depreciation and Amortization |
0.00%
0.20
|
0.20 | 0.20 | 0.20 | 0.20 |
| Operating Income/Loss |
21.37%
-37.76
|
-48.02 | -53.27 | -36.78 | -32.20 |
| Income/Loss From Continuing Operations Before Tax |
21.75%
-35.58
|
-45.47 | -50.99 | -34.16 | -30.18 |
| Income/Loss From Continuing Operations After Tax |
21.75%
-35.58
|
-45.47 | -50.99 | -34.16 | -30.18 |
|
Net Income/Loss
|
21.75%
-35.58
|
-45.47 | -50.99 | -34.16 | -30.18 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,375%
50.12
|
2.0248 | 41.15 | 40.88 | 40.86 |
| Diluted Average Shares |
2,375%
50.12
|
2.0248 | 41.15 | 40.88 | 40.86 |
| Basic Earnings Per Share |
22.83%
-0.71
|
-0.92 | -1.24 | -0.84 | -0.74 |
| Diluted Earnings Per Share |
22.83%
-0.71
|
-0.92 | -1.24 | -0.84 | -0.74 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):